We cultured tumor cells derived from five patients with MET-amplified non-small cell lung cancer into in vitro patient-derived organoids (PDO) and experimentally assessed the resulting cell viability under different cytotoxic treatments. The gene discussed is MET; the disease is non-small cell lung carcinoma.